Healthcare stocks: fair value overview
Updated 2026-08-30 · 152 stocks covered
Of the 152 Healthcare stocks in TickrTrends' weekly Forward Fair Value coverage, 53 currently screen as undervalued, 34 as fairly valued and 26 as overvalued, while 39 await sufficient validated earnings history for a full verdict.
- A — Agilent Technologies, Inc.$153.84Fairly valued
- ABBV — AbbVie Inc.$255.48Fairly valued
- ABT — Abbott Laboratories$112.47Undervalued
- ACAD — ACADIA Pharmaceuticals Inc.$25.61Overvalued
- ACHC — Acadia Healthcare Company, Inc.$30.59Fairly valued
- ADMA — ADMA Biologics, Inc.$8.74Undervalued
- ALGN — Align Technology, Inc.$157.58Undervalued
- ALHC — Alignment Healthcare, Inc.$14.56Limited data
- ALKS — Alkermes plc$49.53Overvalued
- ALNY — Alnylam Pharmaceuticals, Inc.$220.33Limited data
- ALVO — Alvotech$3.79Limited data
- AMGN — Amgen Inc.$432.42Overvalued
- AMPH — Amphastar Pharmaceuticals, Inc.$20.22Undervalued
- ANAB — AnaptysBio, Inc.$53.66Limited data
- ANIP — ANI Pharmaceuticals, Inc.$80.06Undervalued
- ASND — Ascendis Pharma A/S$243.45Limited data
- ASTH — Astrana Health, Inc.$35.91Undervalued
- ATEC — Alphatec Holdings, Inc.$10.15Limited data
- AVAH — Aveanna Healthcare Holdings Inc.$9.61Undervalued
- AXGN — Axogen, Inc.$45.73Limited data
- AXSM — Axsome Therapeutics, Inc.$211.04Limited data
- AZN — AstraZeneca PLC$156.93Undervalued
- AZTA — Azenta, Inc.$29.88Fairly valued
- BAX — Baxter International Inc.$26.13Fairly valued
- BDX — Becton, Dickinson and Company$189.52Fairly valued
- BIIB — Biogen Inc.$218.50Fairly valued
- BIO — Bio-Rad Laboratories, Inc.$330.01Overvalued
- BLFS — BioLife Solutions, Inc.$32.15Limited data
- BLLN — BillionToOne, Inc.$137.32Limited data
- BLTE — Belite Bio, Inc$154.79Limited data
- BMY — Bristol-Myers Squibb Company$66.58Overvalued
- BSX — Boston Scientific Corporation$46.84Undervalued
- BTSG — BrightSpring Health Services, Inc.$60.47Undervalued
- BVS — Bioventus Inc.$13.47Fairly valued
- CAH — Cardinal Health, Inc.$234.55Overvalued
- CAI — Caris Life Sciences, Inc.$16.32Limited data
- CDNA — CareDx, Inc.$47.85Overvalued
- CI — The Cigna Group$278.88Undervalued
- CLOV — Clover Health Investments, Corp.$4.33Limited data
- CNC — Centene Corporation$64.75Overvalued
- COLL — Collegium Pharmaceutical, Inc.$35.58Undervalued
- COO — The Cooper Companies, Inc.$71.17Undervalued
- COR — Cencora, Inc.$322.03Fairly valued
- CRL — Charles River Laboratories International, Inc.$291.50Overvalued
- CTKB — Cytek Biosciences, Inc.$4.31Limited data
- CVS — CVS Health Corporation$93.06Overvalued
- DGX — Quest Diagnostics Incorporated$242.76Overvalued
- DHR — Danaher Corporation$216.07Fairly valued
- DVA — DaVita Inc.$180.68Undervalued
- DXCM — DexCom, Inc.$90.82Undervalued
- ELV — Elevance Health, Inc.$394.43Fairly valued
- EMBC — Embecta Corp.$3.72Undervalued
- ENSG — The Ensign Group, Inc.$177.23Fairly valued
- EOLS — Evolus, Inc.$6.05Limited data
- ETON — Eton Pharmaceuticals, Inc.$45.14Limited data
- EW — Edwards Lifesciences Corporation$90.21Undervalued
- EXEL — Exelixis, Inc.$55.06Undervalued
- GEHC — GE HealthCare Technologies Inc.$71.72Undervalued
- GILD — Gilead Sciences, Inc.$145.68Overvalued
- GMAB — Genmab A/S$28.68Undervalued
- HALO — Halozyme Therapeutics, Inc.$82.27Undervalued
- HCA — HCA Healthcare, Inc.$417.82Fairly valued
- HCSG — Healthcare Services Group, Inc.$23.41Fairly valued
- HQY — HealthEquity, Inc.$104.36Undervalued
- HSIC — Henry Schein, Inc.$89.52Fairly valued
- HSTM — HealthStream, Inc.$28.33Undervalued
- HUM — Humana Inc.$385.54Overvalued
- IDXX — IDEXX Laboratories, Inc.$554.99Undervalued
- ILMN — Illumina, Inc.$198.16Overvalued
- INCY — Incyte Corporation$124.37Undervalued
- INDV — Indivior Pharmaceuticals, Inc.$37.37Undervalued
- INMD — InMode Ltd.$15.35Overvalued
- INNV — InnovAge Holding Corp.$11.23Limited data
- INSM — Insmed Incorporated$98.45Limited data
- INVA — Innoviva, Inc.$20.77Fairly valued
- IQV — IQVIA Holdings Inc.$261.75Fairly valued
- ISRG — Intuitive Surgical, Inc.$372.60Undervalued
- JAZZ — Jazz Pharmaceuticals plc$251.58Fairly valued
- JNJ — Johnson & Johnson$268.04Overvalued
- KNSA — Kiniksa Pharmaceuticals International, plc$73.41Fairly valued
- LEGN — Legend Biotech Corporation$19.01Limited data
- LFST — LifeStance Health Group, Inc.$10.54Limited data
- LGND — Ligand Pharmaceuticals Incorporated$292.04Overvalued
- LH — Labcorp Holdings Inc.$335.11Overvalued
- LIVN — LivaNova PLC$82.46Fairly valued
- LLY — Eli Lilly and Company$1,174.61Undervalued
- LMAT — LeMaitre Vascular, Inc.$103.61Undervalued
- LNTH — Lantheus Holdings, Inc.$101.19Overvalued
- LQDA — Liquidia Corporation$83.85Limited data
- MCK — McKesson Corporation$893.39Fairly valued
- MDGL — Madrigal Pharmaceuticals, Inc.$482.00Limited data
- MDLN — Medline Inc.$40.47Limited data
- MDT — Medtronic plc$91.23Fairly valued
- MDXG — MiMedx Group, Inc.$4.27Overvalued
- MEDP — Medpace Holdings, Inc.$573.29Overvalued
- MMED — MiniMed Group, Inc.$19.10Limited data
- MMSI — Merit Medical Systems, Inc.$85.53Undervalued
- MNKD — MannKind Corporation$3.80Undervalued
- MOH — Molina Healthcare, Inc.$200.00Overvalued
- MRK — Merck & Co., Inc.$148.35Overvalued
- MTD — Mettler-Toledo International Inc.$1,398.58Undervalued
- NAGE — Niagen Bioscience, Inc.$3.53Fairly valued
- NBIX — Neurocrine Biosciences, Inc.$166.23Undervalued
- NEO — NeoGenomics, Inc.$15.84Limited data
- NEOG — Neogen Corporation$11.90Fairly valued
- OFIX — Orthofix Medical Inc.$12.26Undervalued
- OMCL — Omnicell, Inc.$37.65Undervalued
- OMDA — Omada Health, Inc.$20.51Limited data
- ONC — BeOne Medicines AG$313.77Limited data
- OPCH — Option Care Health, Inc.$23.70Undervalued
- PAHC — Phibro Animal Health Corporation$37.15Fairly valued
- PFE — Pfizer Inc.$27.96Overvalued
- PGEN — Precigen, Inc.$6.61Limited data
- PGNY — Progyny, Inc.$31.53Undervalued
- PHAT — Phathom Pharmaceuticals, Inc.$8.98Limited data
- PNTG — The Pennant Group, Inc.$40.18Fairly valued
- PODD — Insulet Corporation$145.13Undervalued
- PTCT — PTC Therapeutics, Inc.$68.11Limited data
- QDEL — QuidelOrtho Corporation$17.71Undervalued
- REGN — Regeneron Pharmaceuticals, Inc.$794.19Fairly valued
- RMD — ResMed Inc.$240.33Undervalued
- RVTY — Revvity, Inc.$128.80Overvalued
- SHC — Sotera Health Company$17.99Fairly valued
- SNY — Sanofi$42.95Undervalued
- SOLV — Solventum Corporation$91.12Fairly valued
- STAA — STAAR Surgical Company$24.34Undervalued
- STE — STERIS plc$233.78Undervalued
- SYK — Stryker Corporation$330.69Undervalued
- TALK — Talkspace, Inc.$5.21Limited data
- TBPH — Theravance Biopharma, Inc.$16.87Limited data
- TCMD — Tactile Systems Technology, Inc.$29.78Overvalued
- TECH — Bio-Techne Corporation$72.35Undervalued
- TFX — Teleflex Incorporated$141.56Undervalued
- TGTX — TG Therapeutics, Inc.$46.17Undervalued
- TLX — Telix Pharmaceuticals Limited$10.02Limited data
- TMDX — TransMedics Group, Inc.$81.55Undervalued
- TMO — Thermo Fisher Scientific Inc.$622.18Fairly valued
- TNDM — Tandem Diabetes Care, Inc.$20.11Limited data
- TVTX — Travere Therapeutics, Inc.$54.98Limited data
- TXG — 10x Genomics, Inc.$47.01Limited data
- UHS — Universal Health Services, Inc.$171.66Undervalued
- UNH — UnitedHealth Group Incorporated$392.95Undervalued
- VCEL — Vericel Corporation$46.05Limited data
- VCYT — Veracyte, Inc.$44.85Fairly valued
- VNDA — Vanda Pharmaceuticals Inc.$5.23Undervalued
- VRTX — Vertex Pharmaceuticals Incorporated$541.69Fairly valued
- VTRS — Viatris Inc.$16.34Limited data
- WAT — Waters Corporation$414.69Fairly valued
- WST — West Pharmaceutical Services, Inc.$337.47Fairly valued
- ZBH — Zimmer Biomet Holdings, Inc.$100.91Undervalued
- ZTS — Zoetis Inc.$77.34Undervalued
- ZYME — Zymeworks Inc.$21.81Limited data